Expression of p53, Bcl2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines
1998

Cisplatin-Induced Apoptosis in Testicular Germ Cell Tumor Cell Lines

Sample size: 4 publication Evidence: moderate

Author Information

Author(s): H Burger, K Nooter, AWM Boersma, CJ Kortland, G Stoter

Primary Institution: University Hospital Rotterdam and Rotterdam Cancer Institute

Hypothesis

Does the presence of wild-type p53 correlate with sensitivity to cisplatin-induced apoptosis in testicular germ cell tumor cell lines?

Conclusion

The study suggests that hypersensitivity to cisplatin-induced apoptosis in testicular germ cell tumor cell lines may not be directly correlated with the presence of wild-type p53 or the expression of Bcl-2 and Bax.

Supporting Evidence

  • Three of four testicular germ cell tumor cell lines were hypersensitive to cisplatin-induced apoptosis.
  • The resistant cell line 2102 EP showed minimal apoptosis even at high drug concentrations.
  • Induction of apoptosis correlated with drug sensitivity in the MTT assay.
  • Wild-type p53 was up-regulated in sensitive cell lines but not in resistant ones.
  • Endogenous levels of Bcl-2 and Bax did not correlate with cisplatin-induced apoptosis.

Takeaway

Some testicular cancer cells are very sensitive to a drug called cisplatin, but having a specific protein called p53 doesn't always mean they will respond to the drug.

Methodology

The study examined four testicular germ cell tumor cell lines for their sensitivity to cisplatin-induced apoptosis and analyzed the expression of p53, Bcl-2, and Bax proteins.

Limitations

The study is limited to a small panel of cell lines and may not represent all testicular germ cell tumors.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication